Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ANG 003

Next Previous
Drug Profile

ANG 003

Alternative Names: Amylase/Lipase/Protease replacements - Anagram Therapeutics; ANG-003; SNSP-003

Latest Information Update: 20 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Synspira
  • Developer Anagram Therapeutics
  • Class Enzymes
  • Mechanism of Action Amylase replacements; Enzyme replacements; Lipase replacements; Peptide hydrolase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Exocrine pancreatic insufficiency
  • Preclinical Malabsorption syndromes

Most Recent Events

  • 20 Aug 2024 Anagram Therapeutics completes a phase-I clinical trials in Exocrine pancreatic insufficiency in USA (PO) (NCT06052293)
  • 04 Oct 2023 ATUM announces an expanded partnership with Anagram Therapeutics to co-develop ANG 003 for Exocrine pancreatic insufficiency
  • 25 Aug 2023 Phase-I clinical trials in Exocrine pancreatic insufficiency in USA (PO) (NCT06052293)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top